Centella is already a known skin-care ingredient under the cica label. The Foresight opportunity is the migration from topical repair into ingestible and hybrid beauty-health products. When an ingredient already has consumer recognition on the outside of the body, brands can sometimes move it inward if the evidence, dose, and safety story are clean enough.
The first products will likely be oral beauty capsules, drink powders, scalp-care bundles, and paired topical-plus-ingestible programs. The consumer is not only thinking about a skin concern; she is buying barrier support, recovery, healthy aging, and visible resilience. That makes centella relevant to beauty brands, supplement brands, and hair/scalp companies at the same time.
South Korea and Japan are logical early markets because beauty-from-within and cica skin care are already mainstream there. Malaysia, Vietnam, and Thailand are relevant supply and botanical-knowledge regions. The premium U.S. channel could follow once brands make the bridge from skin-care familiarity to credible oral formats.
The companies to watch are cica skin-care companies, beauty supplement brands, plant extracellular-vesicle developers, and scalp-health innovators. The read strengthens when brands launch clean oral-plus-topical systems with measured skin, hair, or comfort outcomes rather than generic botanical wellness language.